CN118556055A - 蛋白酪氨酸磷酸酶抑制剂及其使用方法 - Google Patents

蛋白酪氨酸磷酸酶抑制剂及其使用方法 Download PDF

Info

Publication number
CN118556055A
CN118556055A CN202280088452.2A CN202280088452A CN118556055A CN 118556055 A CN118556055 A CN 118556055A CN 202280088452 A CN202280088452 A CN 202280088452A CN 118556055 A CN118556055 A CN 118556055A
Authority
CN
China
Prior art keywords
hydroxy
fluoro
dihydro
benzothiopyran
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280088452.2A
Other languages
English (en)
Chinese (zh)
Inventor
A·博丹
C·伊科诺牟
J·M·弗罗斯特
P·R·凯姆
S·O·肖尔茨
Z·熊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Inc
Calico Life Sciences LLC
Original Assignee
AbbVie Inc
Calico Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AbbVie Inc, Calico Life Sciences LLC filed Critical AbbVie Inc
Publication of CN118556055A publication Critical patent/CN118556055A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN202280088452.2A 2021-11-11 2022-11-10 蛋白酪氨酸磷酸酶抑制剂及其使用方法 Pending CN118556055A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163278336P 2021-11-11 2021-11-11
US63/278336 2021-11-11
PCT/US2022/049581 WO2023086495A1 (en) 2021-11-11 2022-11-10 Protein tyrosine phosphatase inhibitors and methods of use thereof

Publications (1)

Publication Number Publication Date
CN118556055A true CN118556055A (zh) 2024-08-27

Family

ID=84887566

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280088452.2A Pending CN118556055A (zh) 2021-11-11 2022-11-10 蛋白酪氨酸磷酸酶抑制剂及其使用方法

Country Status (8)

Country Link
US (1) US20250042894A1 (cg-RX-API-DMAC7.html)
EP (1) EP4430039A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024543451A (cg-RX-API-DMAC7.html)
CN (1) CN118556055A (cg-RX-API-DMAC7.html)
AU (1) AU2022386164A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236853A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024005656A (cg-RX-API-DMAC7.html)
WO (1) WO2023086495A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024243441A1 (en) 2023-05-24 2024-11-28 Kumquat Biosciences Inc. Heterocyclic compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA94921C2 (en) * 2005-12-08 2011-06-25 Новартис Аг 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
TWI888352B (zh) * 2018-06-21 2025-07-01 美商嘉來克生命科學有限責任公司 蛋白質酪胺酸磷酸酯酶抑制劑及其使用方法
KR102983496B1 (ko) * 2019-03-14 2026-06-29 칼리코 라이프 사이언시스 엘엘씨 단백질 티로신 포스파타제 억제제 및 이의 사용 방법
MX2022007441A (es) * 2019-12-18 2022-09-02 Calico Life Sciences Llc Inhibidores de proteína tirosina fosfatasa y sus métodos de uso.

Also Published As

Publication number Publication date
AU2022386164A1 (en) 2024-05-23
JP2024543451A (ja) 2024-11-21
EP4430039A1 (en) 2024-09-18
CA3236853A1 (en) 2023-05-19
MX2024005656A (es) 2024-08-06
US20250042894A1 (en) 2025-02-06
WO2023086495A1 (en) 2023-05-19

Similar Documents

Publication Publication Date Title
EP3728238B1 (en) Sulphonyl urea derivatives as nlrp3 inflammasome modulators
JP6256772B2 (ja) ヒストンデメチラーゼ阻害剤
JP2022106844A (ja) Jakファミリーのキナーゼの阻害剤としてのイミダゾピロロピリジン
JP2026509001A (ja) E.g.癌を治療するためのras-pi3kモジュレーターとしての1-(([1,1’,-ビフェニル]-2-イル)スルホニル)-4-フルオロ-n-(3-(メチルスルホニル)アリル)ピペリジン-4-カルボキサミド誘導体
CN114173803A (zh) 氨基酸化合物的剂型和方案
AU2015339196A1 (en) Substituted tetrahydropyrans and method of use
JP2008208129A (ja) Pparアゴニスト活性を有する誘導体
AU2009205070A1 (en) Phenyl acetamide derivative
WO2021161105A1 (en) P2x3 modulators
CN120303272A (zh) Nlrp3的抑制剂
EP3400226A1 (en) Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer
CN118525016A (zh) 蛋白酪氨酸磷酸酶抑制剂及其使用方法
WO2019241751A1 (en) Ssao inhibitors and uses thereof
JPWO2011043381A1 (ja) ピラゾロチアゾール化合物
JP2024543451A (ja) プロテインチロシンホスファターゼ阻害剤及びその使用方法
WO2022092141A1 (ja) 抗ウイルス活性を有するアミド誘導体
CN105358551A (zh) Ccr2的八氢环戊并吡咯基拮抗剂
AU2017226674A1 (en) 5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative
JP3999861B2 (ja) 新規ピリダジン誘導体及びこれを有効成分とする医薬
RU2836730C1 (ru) Амидное производное, имеющее противовирусную активность
WO2025237404A1 (zh) 一种mc4r拮抗剂的多晶型物及其制备方法和应用
WO2024152995A1 (zh) 一种大环类细胞周期蛋白抑制剂及其制备方法和应用
WO2026002203A1 (zh) 组织蛋白酶c抑制剂化合物及其应用
HK40070149A (en) Dosage forms and regimens for amino acid compounds
HK40039990B (en) Sulphonyl urea derivatives as nlrp3 inflammasome modulators

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination